The reborn Ford Escort RS will be powered by a new four-cylinder engine that produces 325bhp and revs out to 10,000rpm while weighing just 85kg. Built by Coventry-based Boreham Motorworks and named the Ten-K in reference to its high rev limit, it mirrors the original Escort RS1600’s Cosworth BDA engine in being a belt-driven unit with… Continue reading Reborn Ford Escort RS to rev to 10,000rpm
Category: News Type
@niche: Workhorse Group Inc (WKHS) Q3 2025 Earnings Call Highlights: Strategic Moves and Financial …004149
This article first appeared on GuruFocus. Revenue: $2.4 million for Q3 2025, a decrease from $2.5 million in Q3 2024. Cost of Sales: $10.1 million for Q3 2025, up from $6.6 million in Q3 2024. Selling, General and Administrative Expenses (SG&A): $7.8 million for Q3 2025, slightly up from $7.7 million in Q3 2024. Research… Continue reading @niche: Workhorse Group Inc (WKHS) Q3 2025 Earnings Call Highlights: Strategic Moves and Financial …004149
FOTON Charts a New Course for Global Commercial Vehicles
BEIJING, Nov. 12, 2025 /PRNewswire/ — On November 9th, FOTON Motor held its 2026 Global Partners Conference in Beijing under the theme “DRIVE TO GREAT.” The event gathered over 2,000 attendees from more than 140 countries to witness FOTON’s major breakthroughs in product innovation and strategy, showcasing its commitment to driving the industry’s transformation with green… Continue reading FOTON Charts a New Course for Global Commercial Vehicles
Ardagh Announces Amicable Agreement and Settlement Date
THIS ANNOUNCEMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION Ardagh announces amicable agreement with financial creditors and stakeholders and expected completion… Continue reading Ardagh Announces Amicable Agreement and Settlement Date
Clarivate Announces Highly Cited Researchers 2025 List
Celebrating exceptional, community-wide excellence, based on rigorous evaluation and selection LONDON, Nov. 12, 2025 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the Highly Cited Researchers 2025 list. This annual list recognizes researchers whose contributions have demonstrated broad and significant influence in their fields. Analysts from the Institute for Scientific… Continue reading Clarivate Announces Highly Cited Researchers 2025 List
Accor shapes the future of hospitality with a bold vision, global mindset, and passion for sustainability
AROUND THE WORLD, ACCOR CONTINUES TO ENRICH THE TOURISM LANDSCAPE WITH MORE BRANDS, NEW PROPERTIES, AND INNOVATIVE STYLES OF HOSPITALITY PARIS, Nov. 12, 2025 /PRNewswire/ – Accor, a world-leading hospitality group, today provided a strategic update on its global growth and development activity while attending TOURISE in Riyadh, Saudi Arabia, the first global platform to unite… Continue reading Accor shapes the future of hospitality with a bold vision, global mindset, and passion for sustainability
Accor shapes the future of hospitality with a bold vision, global mindset, and passion for sustainability
AROUND THE WORLD, ACCOR CONTINUES TO ENRICH THE TOURISM LANDSCAPE WITH MORE BRANDS, NEW PROPERTIES, AND INNOVATIVE STYLES OF HOSPITALITY PARIS, Nov. 12, 2025 /PRNewswire/ — Accor, a world-leading hospitality group, today provided a strategic update on its global growth and development activity while attending TOURISE in Riyadh, Saudi Arabia, the first global platform to unite… Continue reading Accor shapes the future of hospitality with a bold vision, global mindset, and passion for sustainability
AbolerIS Pharma Announces Publication in Molecular Therapy Cell Press Journal of New Preclinical Results Supporting Mechanism of Action of ABO21009, a First-in-Class Anti-CD45RC Antibody, Currently in Phase 1
-Results highlight the potential to transform treatment of autoimmune diseases, organ transplant rejection and GVHD- GOSSELIES, Belgium and NANTES, France, Nov. 12, 2025 /PRNewswire/ — AbolerIS Pharma (“AbolerIS”), a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from autoimmune diseases, today announced the publication of new preclinical findings describing the mechanism of action… Continue reading AbolerIS Pharma Announces Publication in Molecular Therapy Cell Press Journal of New Preclinical Results Supporting Mechanism of Action of ABO21009, a First-in-Class Anti-CD45RC Antibody, Currently in Phase 1
BLOXX Launches World’s First Home Equity Subscription, Creating a New Residential Asset Class
BLOXX’s new home equity subscription aims to unlock homeownership for 1 million renters globally, starting with just 1% deposit LONDON, Nov. 12, 2025 /PRNewswire/ — Bloxx, a fintech founded by former banking executive Chris Smith and co-founder Cliff Curtis, today announced the global launch of its home equity subscription platform. The platform introduces a revolutionary… Continue reading BLOXX Launches World’s First Home Equity Subscription, Creating a New Residential Asset Class
HS Hyosung Signs Joint Venture Agreement with Umicore for Next-Generation Anode Material Business
– Anticipated annual 40% growth through graphite substitution… Securing a future growth engine for the Group – Acquiring foundational technology for “game-changing” high-efficiency, fast-charging next-generation batteries – Personally led by Vice Chairman Cho Hyun-Sang, emphasizing “value maximization through technology and intellectual assets” – Strengthening South Korea’s global supply chain competitiveness through domestic investment and job… Continue reading HS Hyosung Signs Joint Venture Agreement with Umicore for Next-Generation Anode Material Business